The global biologics market is estimated to grow at a CAGR of 8.6% during the forecast period. Some pivotal factors encouraging market growth include the rising incidences of cancer and rising investments in the development of biologics. Rising cancer incidences are the major factor accelerating the demand for biologics. As per the World Health Organization (WHO), the cancer burden globally is estimated to have increased to 18.1 million new incidences in 2018. 1 in 5 men and 1 in 6 women globally develop cancer during their lifetime. The total number of people globally who are alive within 5 years of a cancer diagnosis, known as a 5-year prevalence, is estimated to be 43.8 million in 2018.

Free Sample Copy @ https://www.omrglobal.com/request-sample/biologics-market

The global biologics market is segmented based on product and application. Based on the product, the market is segmented into antibody therapeutics, vaccines, cell therapy, gene therapy, and others. Based on application, the market is segmented into cancer, autoimmune diseases, infectious diseases, and others.

A Full Report of Global Biologics Market is Available at:
https://www.omrglobal.com/industry-reports/biologics-market

In 2019, North America held the largest share in the market owing to the rising cancer incidences and significant FDA approvals for monoclonal antibodies. For instance, as per the Centers for Disease Control and Prevention (CDC), the number of new cancer incidences in the US is expected to grow from nearly 1.5 million annually in 2010 to 1.9 million annually in 2020. The rising cancer incidences are leading to increasing demand for biologics which comprises a comprehensive range of drugs that particularly target cancer cells, encourage the immune response, and support in the recovery from cancer treatment. These drugs are normally utilized in combination with other therapies, including chemotherapy.

Global Biologics Market – Segmentation
by Product
Antibody Therapeutics
Vaccines
Cell Therapy
Gene Therapy
Others
by Application
Cancer
Autoimmune Diseases
Infectious Diseases
Others

Global Biologics Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
AbbVie Inc.
Amgen Inc.
AstraZeneca plc (UK)
Aurobindo Pharma Ltd.
Baxter International Inc. (US)
Biocon Ltd.
Biological E. Limited (BE)
Boehringer Ingelheim GmbH (Germany)
Bristol Myers Squibb Co. (UK)
Cipla Ltd. (India)
Daiichi Sankyo Company, Ltd. (Japan)
Eli Lilly and Co.
F. Hoffmann-La Roche AG
GlaxoSmithKline PLC
H. Lundbeck A/S
Johnson & Johnson Services, Inc.
Merck & Co., Inc.
Novo Nordisk A/S
Pfizer Inc.
Sanofi SA
Smith & Nephew PLC.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/biologics-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404